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GLUTBeyond its general role as antioxidant, speciﬁc functions of ascorbate are compartmentalizedwithin the eukaryotic
cell. The list of organelle-speciﬁc functions of ascorbate has been recently expanded with the epigenetic role
exerted as a cofactor for DNA and histone demethylases in the nucleus. Compartmentation necessitates the trans-
port through intracellularmembranes;members of theGLUT family and sodium-vitaminC cotransportersmediate
the permeation of dehydroascorbic acid and ascorbate, respectively. Recent observations show that increased con-
sumption and/or hindered entrance of ascorbate in/to a compartment results in pathological alterations partially
resembling to scurvy, thus diseases of ascorbate compartmentation can exist. The review focuses on the reactions
and transporters that canmodulate ascorbate concentration and redox state in three compartments: endoplasmic
reticulum, mitochondria and nucleus. By introducing the relevant experimental and clinical ﬁndings we make an
attempt to coin the term of ascorbate compartmentation disease.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
During the elapsed 80 years since thediscovery of ascorbic acid (AA)
as the antiscorbutic vitamin [1], the knowledge on its biological func-
tions, absorption, distribution, catabolism and excretion has been nota-
bly expanded. Ascorbate functions started to be deﬁned not only in the
whole body, but also on cellular or even subcellular levels. Ascorbate de-
ﬁciency results in the development of scurvy in species unable to syn-
thesize this compound (e.g. in humans). It has been hypothesized that
decreased transport of vitamin C into the cells may cause latent or intra-
cellular scurvy. This theory already assumed the role of transporters in
the pathogenesis. Recent observations suggest that subcellular scurvy
may also exist; decreased ascorbate transport into or increasedtortuosity syndrome; DHA,
ulonolactone oxidase; HIF, hyp-
lutarate; PDI, protein disulﬁde
oxygen species; SVCT, sodium-
cation
emistry, Molecular Biology and
, PO Box 260, Budapest 1444,consumption within a compartment results in scurvy-like phenotype
even in an ascorbate synthesizing species.
Almost all known functions of AA are based on its easy oxidability:
ascorbate can undergo two consecutive, one-electron oxidations
resulting in the formation of ascorbyl radical and dehydroascorbic acid
(DHA). Being an excellent electron donor, AA distinguished itself as a
major water-soluble antioxidant [2]. AA efﬁciently detoxiﬁes reactive
oxygen (ROS) and nitrogen (RNS) species, which are commonly formed
during themetabolism and in stress situations, and could damage cellu-
lar components (Fig. 1). In addition, AA serves as a reducing cofactor for
many enzymes, including copper-containing monooxygenases [3] and
Fe(II)/2-oxoglutarate (2OG)-dependent dioxygenases [4] (Fig. 1).
Through these enzymatic reactions AA is required for the synthesis of
carnitine [5] and catecholamines [6], as well as the posttranslational
modiﬁcation of extracellular matrix proteins, including collagen [7,8].
Moreover, AA-dependent regulatory processes have been also emerged,
such as normoxia–hypoxia response by hypoxia inducible factor (HIF)
hydroxylation [9] and epigenetically relevant oxidation reactions affect-
ing methylated histones and nucleic acids [10].
AA utilizing reactions can be found in all subcellular compart-
ments of mammalian cells. The antioxidant function is presumably
present everywhere with an emphasis on the oxidative organelles
such as mitochondria, peroxisomes and endoplasmic reticulum
Fig. 1.Ascorbate as electron donor. Ascorbate (AA) can reactwith free radicals and other re-
active species in spontaneous non-enzymatic reactions (a). AA is an electron donor for
copper-containingmonooxygenases, such as dopamine β-hydroxylase and peptidylglycine
α-hydroxylating monooxygenase. Ascorbate reduces the copper sites to the catalytically
active Cu+ form (b). AA is required for the regeneration of Fe(II) in catalysis by Fe(II)/
2OG-dependent dioxygenases of hydroxylation (c) or demethylation (d) of different
substrates.
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different compartments, e.g. HIF prolyl hydroxylases are present in
the cytosol, collagen prolyl/lysil hydroxylases in the ER lumen [7,8],
dopamine β-monooxygenase and peptidylglycine α-hydroxylating
monooxygenase in the chromafﬁn granules, synaptic and secretory
vesicles [11], histone and DNA demethylases in the nucleoplasm.
Since AA and its oxidized products are charged and water-soluble mol-
ecules, transporters are crucial to keep vitamin C concentrations opti-
mal in the organelles. AA/DHA transporters have been essentially
characterized in the plasma membrane (Fig. 2). AA can be taken up by
a secondary active transport mediated by sodium-dependent vitamin
C transporters SVCT1 (SLC23A1) and SVCT2 (SLC23A2). SVCT1 is
expressed in epithelial tissues, contributing to the maintenance of
whole-body vitamin C levels, whereas the expression of SVCT2 is rela-
tively widespread (for a recent review see [12]). DHA, the oxidized
form of AA is taken up by facilitated diffusionmediated by themembers
of the GLUT family [13]. For example, in SVCT1 knockout mice the
absorption of vitamin C can be normalized by adding DHA to the diet,
which crosses the intestinal epithelium via GLUTs of the plasma mem-
brane [14]. Nonetheless, under normal circumstances DHA transport
is thought to be less signiﬁcant since DHA is unstable and therefore
present at low concentrations in extra/intracellular compartments.
However, GLUT-dependent uptake becomes more intense in oxidative
stress and can be stimulated by extracellular oxidants or by a localFig. 2. Possible mechanisms of ascorbate transport through membranes. Ascorbate anion
(AA−) can be transported by secondary active transport by using the concentration gradi-
ent formed by a cation pump (a). Facilitated diffusion of dehydroascorbic acid (DHA) can
be mediated by different GLUT transporters (b). Since cellular DHA concentrations are
extremely low, DHA transport might be facilitated by an ascorbate oxidase on the cis
and a DHA reductase on the trans side of the membrane (c). Note that only mechanisms
(a) and (c) can generate an AA gradient.oxidase activity [15]. Although the presence and functioning of these
transporters in the plasma membrane are well documented, little is
known about their distribution in the endomembranes. Table 1 shows
the most important characteristics of GLUTs and SVCTs possibly in-
volved in AA/DHA transport in subcellular compartments.
2. Endoplasmic reticulum: ascorbate in dual role
In vertebrates AA is synthesized by the ER-resident integral mem-
brane protein L-gulonolactone oxidase (GLO) with the production of
equimolar hydrogen peroxide as byproduct [32], or taken up with the
diet. Indeed, in certain species including humans, GLO is mutated and
fully inactive [33] and the presence of vitamin C in the diet is essential.
Hepatic AA synthesis is accompanied with intraluminal oxidation of
glutathione [34–36] and protein thiols [37,38] likely due to hydrogen
peroxide formation within the ER. These ﬁndings, together with the
predicted membrane topology of GLO suggest the intraluminal orienta-
tion of its active site. Thus, the ER in all cells of vitamin C-dependent spe-
cies needs transport mechanisms to ensure the substrate supply of
intraluminal vitamin C utilizing enzymes. Moreover, being GLO preva-
lently expressed in liver [39,40], transport mechanisms for vitamin C
should be operative in the ER of all extrahepatic cells. In spite of these
considerations, AA/DHA transporters have not been characterized at
molecular level in the ER. A functional study found a preferential DHA
uptake in mammalian ER-derived vesicles and the characteristics of
the transport suggested the involvement of GLUT-type transporter(s)
[41]. In linewith this assumption, itwas observed thatAAhardly crosses
the ER membrane [41] and its oxidation (i.e. DHA formation) is a pre-
requisite of the uptake [42]. An AA oxidase activity associated with the
ER fraction has been also reported [43], as a possible promoter of the up-
take.More recently, GLUT10has beenproposed as anERDHA transport-
er [26], but the fact that its inherited deﬁciency is restricted to certain
cell types only (see below), suggests that other ER DHA transporters
likely exist (Fig. 3). To give a comprehensive view of ascorbate transport
in the ER it should bementioned that partial colocalization of SVCT2 and
protein disulﬁde isomerase (PDI) as a protein marker for ER has been
shown recently. The colocalization results were supported by the
copuriﬁcation of SVCT2with calnexin [29]. Further functional character-
ization of ascorbic acid transport in the ER is required to estimate its
contribution to vitamin C uptake by the organelle.
Luminal AA is required for local antioxidant defense in the ER. Dur-
ing the electron transfer in the ER-resident cytochrome P450 system,
ROS can be formed as a result of chemical accidents [44]. The terminal
oxidase of the oxidative protein folding (Ero1) also generates hydrogen
peroxide in the lumen [45,46]. High local concentration of AA is proba-
bly important to balance these prooxidant events. Moreover, at least in
cells involved in collagen/elastin production, ER luminal Fe(II)/2OG-
dependent dioxygenases (e.g., prolyl hydroxylases and lysyl hydroxy-
lases) also require AA for maintaining the redox state of ferrous iron
at the active site of the enzymes (Fig. 3, reaction as in Fig. 1c) (see [8,
47] for recent reviews).
The reactions above AA behave as an electron donor (Fig. 1). Howev-
er, a pro-oxidant role of AAmight also be present in the ER. DHA, either
formed in local reactions or transported into the lumen of the ER can be
reduced by PDI, oxidizing the active central dithiols of the enzyme; ox-
idized PDI reacts with reduced substrate proteins yielding protein
disulﬁdes and catalytically regenerating PDI (Fig. 3) [48]. Alternatively,
DHA can rapidly react with dithiols in unfolded or partially folded pro-
teins in a PDI-independent manner [49].
In vivo ﬁndings also prove that luminal electron donor and electron
acceptor functions of ascorbate mutually support each other. Results
gained in scorbutic guinea pigs showed that not only prolyl- and lysyl-
hydroxylation was disturbed, but the missing prooxidant effect led to
ER stress, presumably due to an impairment of oxidative protein folding
[50]. Moreover, compromising the oxidative protein folding in mice
with combined loss-of-function mutations in genes of the key enzymes
Table 1
Transporters possibly involved in the transport of ascorbate and dehydroascorbic acid in subcellular compartments.
Transporter Preferred substrates Tissue distribution Subcellular membrane distribution KM Defects associated with the
transporter
GLUT1 Glucose, galactose, mannose,
glucosamine, DHA
Erythrocytes, brain, blood–brain barrier,
blood–tissue barrier, many fetal tissue
Plasma membrane, Golgi apparatus [16],
mitochondrial inner membrane [17]
1.1 mM
[18]
Paroxysmal exertion-induced
dyskinesia, dystonia-18, Glut1
deﬁciency syndrome
GLUT2 Glucose, galactose, fructose,
mannose, glucosamine, DHA
Liver, islet of Langerhans, intestine, kidney,
brain
Plasma membrane 8.4 mM
[19]
Fanconi–Bickel syndrome, (type
2 diabetes)
GLUT3 Glucose, galactose, mannose,
xylose, DHA
Brain (neurons), testis Plasma membrane 1.7 mM
[18]
GLUT4 Glucose, glucosamine, DHA Adipose tissue (white and brown), skeletal
and cardiac muscle
Endosomal pathway, plasma membrane 0.98 mM
[20]
(type 2 diabetes)
GLUT8 Glucose, fructose, galactose,
DHA
Testis, brain, adrenal gland, liver, spleen,
brown adipose tissue, lung (intracellular)
Plasma membrane, lysosome [21,22] 3.23 mM
[23]
GLUT10 Glucose, galactose, DHA Heart, lung, brain, liver, skeletal muscle,
pancreas, placenta and kidney
Plasma membrane, mitochondrial inner
membrane [24], nuclear envelope [25],
endoplasmic reticulum [26]
N.D. Arterial tortuosity syndrome
SVCT1 L-ascorbic acid Epithelial tissues including kidney,
intestines, liver, lung, skin
Plasma membrane ~90 μM
[27]
SVCT2 L-ascorbic acid Widespread including brain (neurons),
retina, placenta, spleen, prostate, testis,
ovary (rat Svct2 also in lung, adrenal,
osteoblast)
Plasma membrane, mitochondrial inner
membrane [28,29]
60 μM
[27]
If not otherwise indicated (see references), the data of the table aremainly from [30] and [31]. The indicatedKM values are for DHA in the case of GLUT transporters and for ascorbate in the
case of SVCT transporters; for the sake of comparability results obtained in Xenopus oocytes are shown.
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droxyproline formation and defective intracellular maturation of
procollagen. A noncanonical form of scurvy, i.e. ascorbate depletion
was also observed, due to the consumption of ascorbate as a reduc-
tant for sulfenylated protein intermediates of oxidative folding aber-
rantly formed in the absence of ERO1α, ERO1β, and peroxiredoxin 4
[51,52].3. Vitamin C and mitochondria
Although the ﬁrst report on mitochondrial AA/DHA transport was
published more than 30 years ago [53], many details of the transport
became evident in the last few years (see Fig. 4 for a schematic repre-
sentation of AA/DHA transporters in the mitochondria). The previous
ﬁndings that vitamin C can enter plant mitochondria as DHA [54]
were conﬁrmed by Golde and co-workers [17] in animal cells. A
stereo-selective mitochondrial D-glucose uptake mechanism, whichFig. 3. Ascorbate in the ER. Dehydroascorbic acid (DHA), presumably taken up by a GLUT-
type transporter, can efﬁciently oxidize protein- and non-protein thiols in the ER lumen.
Ascorbate (AA) formed in these enzymatic or non-enzymatic reactions supports
the catalytic function of luminal Fe(II)/2OG dependent dioxygenases: prolyl- and lysyl-
hydroxylases.competes with the transport of DHA, was found in the mitochondria
from mammalian cells. In accordance with the computational analysis
of the N-terminal sequences of human GLUT isoforms, the presence
of GLUT1 in mitochondrial membrane was veriﬁed by mitochondrial
expression of GLUT1-EGFP, immunoblot analysis and by cellular
immunolocalization [17].
More recently, GLUT10was also reported to be localized to themito-
chondria of mouse aortic smooth muscle cells and insulin-stimulated
adipocytes [24]. GLUT10 enhanced the entry of radiolabeled DHA into
the mitochondria, which was accompanied with the reduction of ROS
levels in H2O2-treated smooth muscle cells. This protecting effect
could be abolished by glucose pretreatment or by RNA interference of
GLUT10 mRNA expression in smooth muscle cells [24].
Up to now DHA was considered to be the transported form of vita-
min C through the mitochondrial inner membrane. Mitochondrial up-
take and accumulation of the reduced form, AA could not be observed
in the mitochondria from human kidney cells or from rat liver tissue
[17,55]. A recent report on the mitochondrial expression of the sodiumFig. 4. Ascorbate in the mitochondria. Both SVTC and GLUT dependent uptake processes
have been described in the mitochondria. Dehydroascorbic acid (DHA) is reduced back
to ascorbic acid (AA) by various electron donors (glutathione, lipoic acid, pyridine nucle-
otides) in the matrix. AA is predominantly utilized as an antioxidant in the organelle.
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sibility of the existence of ascorbic acid transport through the inner mi-
tochondrial membrane [28,56]. Very recently the relevance of this
transport mechanism has been proven by further experimental results.
Confocal colocalization experiments and immunoblotting of proteins
extracted from highly puriﬁed mitochondrial fractions of HEK-293
cells conﬁrmed that SVCT2 protein was associated mainly with the mi-
tochondria. A substantial level of SVCT2 colocalization could be also ob-
served with the endoplasmic reticulummarker PDI and a very low level
of colocalization with the plasma membrane protein marker GLUT1
[29]. This localization pattern was observed in 16 different human cell
lines including normal, neoplastic and primary cell cultures. The silenc-
ing of SVCT2 expression by SVCT2-siRNA caused the decrease of mito-
chondrial protein abundance of SVCT2 by at least 75%. Consistent with
the decrease of protein abundance the capacity of ascorbate transport
of mitochondria from siRNA-treated cells was only one fourth of the
control cells [29]. The mitochondrial localization of GLUT1 could not
be reinforced in the case of HEK-293 cells, thus the general role of
GLUT1 in mitochondrial vitamin C transport can be queried. The same
research group did not ﬁnd GLUT10 expression in HEK-293 cells [29].
Hence it is hard to say anything about the contribution of this and an-
other GLUT isoform to the transport of vitamin C through themitochon-
drial membrane.
Irrespectively of theway of vitamin C uptake, themitochondriamust
have an efﬁcient mechanism for ascorbate recycling, otherwise DHA
taken up or generated in the matrix would be lost within minutes
under physiological circumstances [57]. Addition of DHA to the mito-
chondria resulted in a reduction of DHA and mitochondrial AA concen-
tration reached the millimolar range [55]. Various mechanisms have
been suggested for intramitochondrial AA recycling. The mitochondria
are capable of reducing DHA to AA in an α-lipoic acid dependent man-
ner [58]. Thioredoxin reductase inmitochondria could also reduce DHA.
However, the inability to detect a signiﬁcant decrease in DHA reduction
by the mitochondria isolated from selenium deﬁcient animals sug-
gested that it is a small component in the mitochondrial DHA reduction
machinery [55]. Since DHA loading caused a signiﬁcant decrease in mi-
tochondrial GSH content and the depletion of mitochondrial GSH con-
tent caused signiﬁcant impairment in DHA reduction, it is likely that
GSH dependent reduction of DHA is one of themajor AA recycling reac-
tions in the mammalian mitochondria [55]. Using speciﬁc substrates
and inhibitors, the role of mitochondrial electron transport chain in
DHA reduction was also described and the site of AA sparing was local-
ized to complex III [59].
The elevated level of ROS can induce the collapse of themitochondri-
al membrane potential, leading to cell death. The mitochondrial mem-
brane potential could be partially conserved and the denaturation and
mitochondrial release of cytochrome c upon H2O2 treatment could
also be avoided by DHA pretreatment in HL-60 cells [60], after FAS-
induced apoptosis in monocytes [61] or in cells undergoing hypoxia-
reperfusion [62]. These ﬁndings suggest that mitochondrial AA is an
important component in the maintenance of the mitochondrial mem-
brane potential and that AA exerts its anti-apoptotic effect through
ROS scavenging [55,60–64]. Furthermore, it was clearly demonstrated
that AA protected mtDNA against the ROS-induced elevation of 8-oxo-
dGuanidine and apurinic/apyrimidinic sites. AA preload could also
signiﬁcantly attenuate the hydrogen peroxide induced shearing of
mtDNA [55]. Theseﬁndingswere conﬁrmedby the signiﬁcant reduction
of hydrogen peroxide induced lesions in mtDNA by vitamin C in retinal
pigment epithelium cells [65]. Thus, experimental data suggest that AA
is predominantly utilized as an antioxidant in the organelle.
4. Ascorbate in the nucleus: regulation of gene expression
It was clearly evident from the previous ample literature that AA
from one hand is able to affect proliferation and differentiation, and
from the other hand to modulate gene expression in a variety of celltypes. AA induces in vitro cell proliferation/differentiation of ﬁbroblasts,
osteoblasts, chondrocytes, myoblasts, and bone-marrow mesenchymal
stem cells (see [66] and refs therein) and, generally speaking, promotes
the cell reprogramming process [67]. AA not only permits collagen hy-
droxylation, but also upregulates procollagen mRNA transcription [68,
69], which has been ascribed to an additional effect of AA onmRNA sta-
bilization [70,71].Moreover, AA treatment upregulates genesmainly in-
volved in neurogenesis in embryonic stem cells [72,73], and affects an
array of genes in cultured ﬁbroblast [74] as well as in the liver of wild-
type [75] and gulonolactone oxidase-deﬁcient [76] mice.
Recent ﬁndings may provide an explanation of effects exerted by AA
on gene expression. Importantly, AA present in the nuclear compart-
ment can well regulate the activity of a variety of AA-dependent en-
zymes catalyzing epigenetically relevant reactions in the nucleus.
These enzymes are Fe(II)/2OG-dependent dioxygenases,which catalyze
the demethylation of histones and nucleic acids aswell as the hydroxyl-
ation of certain histones [77]. Moreover, several Fe(II)/2OG-dependent
dioxygenases can also participate in DNA repairing processes.
The nuclear Fe(II)/2OG-dependent dioxygenases that demethylate
histones mainly belong to the Jumonji protein family conserved from
yeast to humans with a common jmjC functional domain [78]. These en-
zymes appear to be involved in awide variety of biopathological process-
es (reviewed in [10]), including cell proliferation and senescence [79],
carcinogenesis [78,80–82], hepatic gluconeogenesis [83], and somatic
cell reprogramming. It has been recently proposed that Jumonji proteins
can also produce stable hydroxylated histones [84]. Actually, the Jumonji
domain-6 protein appears also to hydroxylate the splicing factor U2
small nuclear ribonucleoprotein auxiliary factor 65-kilodalton sub-
unit (U2AF65) [85], as well as lysine residues of histones H2A/H2B
and H3/H4 [86], in an Fe(II)/2OG-dependent fashion.
Active DNA demethylation refers to an enzymatic process that
removes or modiﬁes the methyl group from 5-methylcytosine as illus-
trated in [87]. The TET (ten–eleven translocation) family comprises at
least three Fe(II)/2OG-dependent dioxygenases, Tet1, Tet2 and Tet3
(see [10] for references), which hydroxylate DNA 5-methylcytosine
yielding the ‘sixth base’ 5-hydroxymethylcytosine. Moreover, TET can
iteratively oxidize 5-methylcytosine to 5-hydroxymethylcytosine, 5-
formylcytosine, and 5-carboxylcytosine, although the levels of the latter
two products are at least an order of magnitude less than those of 5-
methylcytosine [88,89]. A wide literature [10,87,90–93] indicates that
DNAdemethylation is a crucial tool tomodulate gene expression during
embryogenesis, cell reprogramming and stem cell differentiation, as
well as in cancer cells. TET may also participate in DNA repairing pro-
cesses by acting in concert with thymine DNA glycosylase (reviewed
in [87]). Indeed, this latter enzyme can directly excise the Tet products
5-formylcytosine and 5-carboxylcytosine [89,94], ﬁnally leading to the
substitution of the original 5-methylcytosine with the non-methylated
base.
AA appears to enhance 5-hydroxymethylcytosine formation by acting
as a cofactor for TET Fe(II)/2OG-dependent dioxygenases to hydroxylate
5-methylcytosine (as in Fig. 1c). It can be assumed that the role of AA in
the TET-mediated oxidations is to supply the reducing potential necessary
to keep Fe (II) reduced, as is the casewith prolyl-4-hydroxylase-mediated
hydroxylation. In cultured mouse embryonic ﬁbroblasts, it has been re-
cently observed that the effect of AA on 5-methylcytosine hydroxylation
cannot be vicariated by other electron donors such a GSH, is fully inde-
pendent of the cellular uptake of iron, enhanced expression of TET, or
changes in the production of 2OG [95,96]. Contrarily, the size of the in-
tracellular (nuclear?) pool of AA appears to be critical for inducing the
generation of 5-hydroxymethylcytosine [97].
Several nuclear enzymes of the AlkB family proteins are involved in
repairing damage caused by DNA/RNA alkylation. Originally discovered
in Escherichia coli, alkylation protein B (AlkB) belongs to the superfamily
of Fe(II)/2OG-dependent dioxygenases; in mammals, there are at least
nine AlkB homologues: ABH1–ABH8 and FTO (fat mass and obesity as-
sociated) (see [9] and [98] for references). These enzymes repair the
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dealkylation mechanism that is dependent on 2OG, Fe2+ and ascorbate
(see Fig. 1d). AlkB and ABH3 preferentially repair single-stranded DNA
lesions and can also repair methylated bases in RNA, while ABH2 has a
primary role in repairing lesions in double-stranded DNA. FTO has
been shown to catalyze the dealkylation of 3-methylthymine in
single-stranded DNA [99].
Against this background, some questions logically arise. Since vita-
min C is imported from extracellular ﬂuids or synthesized in the ER
compartment, how can AA/DHA reach the nuclear compartment?
Which are the AA/DHA concentration and redox status and how are
they maintained/regulated in the nuclear environment? Little experi-
mental evidence exists to answer these questions.
As to the ﬁrst question, although we cannot presently exclude a di-
rect entry of cytosolic AA (and DHA) into the nucleus across the nuclear
pore, one can speculate that DHA or AA present in nuclear envelope
(NE) – that is a subdomain of ER – can enter into the nucleus across spe-
ciﬁc transporters located at the inner membrane of the NE itself. ER
GLUT transporters (GLUT10?) may mediate DHA entry (Fig. 5); AA
transporters might also be selectively expressed at the NE inner mem-
brane, since its protein composition is known to be different from that
of the NE outer membranes [100]. This phenomenon is not unprece-
dented for charged compounds (such as DHA and AA) since it is
known that both cations and anions can permeate the inner membrane
of theNE via several transporters [101,102]. It should be noted that even
assuming a passage of DHA through the nuclear pore, the larger size of
ER/NE DHA pool – as compared to the cytosolic one – and the large sur-
face of the NE would favor DHA transport from the ER/NE lumen to re-
plenish a nuclear pool.
As to the nuclear AA/DHA concentrations and redox status, the abso-
lute concentrations are unknown but several compounds capable to
ultimately affect the redox couple – GSH [103], NADH [104] or FAD
[105] – are present in the nucleoplasm. Nonetheless, data on enzymatic
connections among them and the AA/DHA redox couple are presently
missing. Irrespectively of the way of getting into, ascorbate concentra-
tion in the nucleoplasm can be an important regulator of epigenetic
events [92,97].Fig. 5.Ascorbate in the nucleus. Hypothetical route of entry of dehydroascorbic acid (DHA)
from a pool present in the endoplasmic reticulum (ER) subdomain nuclear envelope (NE)
through GLUT type transporters (including GLUT10) into the nucleus. In the nucleus, DHA
is supposed to be enzymatically (?) reduced back to ascorbic acid (AA) by undetermined
electron donors (R-H). AA, in turn, supports the catalytic function of Fe(II)/2OG-dependent
dioxygenases involved in oxidative modiﬁcations of histones and nucleic acids.5. Ascorbate compartmentation diseases
Scurvy, the disease of ascorbate deﬁciency, has been known long be-
fore the discovery of AA (see e.g. [106]). Although scurvy is thought to
be primarily due to impaired collagen hydroxylation and production,
the patients present generalized symptoms.
Scurvy at cellular level can be manifested even at normal intake of
vitamin C. The competition between glucose and DHA for GLUT trans-
porters can reduce tissue AA levels in hyperglycemia [107,108]. This
“latent” or “tissue” scurvy thought to be present in insulin dependent
diabetesmellitus can result to endothelial dysfunction and the develop-
ment of atherosclerosis [109].
Recent studies revealed that subcellular scurvy could also exist, due
to either increased consumption of AA in a cellular compartment or
defective transport into an organelle. Thus, disturbances of AA compart-
mentation can be manifested in compartmentation diseases. Zito
and coworkers studied the effect of the combined loss-of-function
mutations in genes encoding the ER thiol oxidases ERO1α, ERO1β, and
peroxiredoxin 4, participating in the electron transfer connected to
oxidative protein folding [51]. Surprisingly, minor alterations only
were found in disulﬁde bond formation, suggesting the presence of
alternative electron transfer routes. Contrarily, low tissue AA con-
centrations and decreased 4-hydroxyproline content of procollagen
were observed in the mice. It was found that in the absence of ER thiol
oxidases, cysteinyl thiol groups were oxidized to sulfenic acid through
an alternative hydrogenperoxide dependentway. Sulfenylated proteins
consumed AA as their reductant [52]. The competition between sulfenic
groups and prolyl hydroxylases for AA in the ER lumen ultimately re-
sulted in impaired procollagen hydroxylation and in the alterations of
extracellular matrix, i.e. in an unorthodox form of scurvy. Although AA
concentration was not measured in the ER lumen, it is obvious that
the primary cause of AA shortage is the enhanced local utilization.
Thus, neither AA synthesis (mice are able to produce AA) nor AA trans-
port could keep pace with the increased consumption.
Another possible example for the importance of AA compartmenta-
tion comes from the human disease arterial tortuosity syndrome (ATS).
This rare congenital connective tissue disorder is characterized by elon-
gation and tortuosity of the major arteries [110]. ATS is due to the mu-
tation of a transporter from the GLUT family, GLUT10 [25]. The
transporter is present in the endomembranes; its existence has been re-
ported in the mitochondria, the ER and the Golgi [24–26]. GLUT10 can
transport DHA, as it was shown in mouse mitochondria [24]. In the
cells presenting pathological signs in ATS (i.e., arterial ﬁbroblasts and
smooth muscle cells) impaired mitochondrial uptake of DHA should
causeAA shortage in thematrix, and a consequent defective elimination
of ROS, leading to cell injury. It should be noted, however, that GLUT10
knockout mice do not present any ATS-like pathology [111], which
raises doubts on the aforementioned mitochondrial hypothesis. It
has been also suggested that the absence of GLUT10 in the ERmay result
in defective collagen/elastine hydroxylation, which may be responsible
for the defects of extracellular matrix [26]. Thus, shortage of AA in a
subcellular compartment, let it be either the mitochondrial matrix or/
and the ER lumen, may be in the background of the pathomechanism
of ATS.
Although the combined loss-of-function mutations of ER thiol oxi-
dases have not been observed in patients and the etiology of ATS has
not been fully elucidated, the above ﬁndings clearly show that distur-
bances in AA compartmentation can be an important factor in the
pathomechanism of different human diseases. Compartment-level
detection of ascorbate concentrations by biochemical approaches
has been an unresolved problem. However, a successful organelle-
speciﬁc detection of ascorbate has been recently reported, by using
immunocytohistochemistry combined with computer supported trans-
mission electron microscopy in plant cells [112,113]. The technique al-
lows the simultaneous investigation of changes in the subcellular
distribution of ascorbate in all compartments of the cell in one
1914 G. Bánhegyi et al. / Biochimica et Biophysica Acta 1843 (2014) 1909–1916experiment. Subcellular mapping of AA concentrations, determination
of the redox state of the AA/DHA redox couple and the exploration of
AA/DHA transportmechanisms in the organelles, both under physiolog-
ical and pathological situations, are future challenges, which will likely
lead to a more detailed understanding of AA compartmentation in
health and disease.
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